Passage Bio, Inc. (PASG) Misses Q3 EPS by 3c

Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Phoenix Education Partners, Inc. (PXED) Misses Q3 EPS by 14c; Offers Outlook
• Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
• Aehr Test Systems (AEHR) Tops Q2 EPS by 12c